BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3530075)

  • 1. A randomized controlled trial of moxalactam versus clindamycin/tobramycin in the treatment of mixed anaerobic/aerobic infections.
    Joshi M; Fitzpatrick BJ; Warren JW; Caplan ES; Tenney JH
    Am Surg; 1986 Sep; 52(9):467-71. PubMed ID: 3530075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moxalactam versus clindamycin plus tobramycin in the treatment of obstetric and gynecologic infections.
    Sweet RL; Ohm-Smith M; Landers DV; Robbie MO
    Am J Obstet Gynecol; 1985 Aug; 152(7 Pt 1):808-17. PubMed ID: 3895947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomized controlled trial of cefoxitin versus clindamycin-aminoglycoside in mixed anaerobic-aerobic infections.
    Drusano GL; Warren JW; Saah AJ; Caplan ES; Tenney JH; Hansen S; Granados J; Standiford HC; Miller EH
    Surg Gynecol Obstet; 1982 May; 154(5):715-20. PubMed ID: 7041297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moxalactam versus clindamycin plus tobramycin for the treatment of puerperal infections.
    Pastorek JG; Faro S; Aldridge KE; Nicaud SK
    South Med J; 1987 Sep; 80(9):1116-9. PubMed ID: 3306943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative clinical study of Sulbactam and ampicillin and clindamycin and tobramycin in infections of soft tissues.
    Stromberg BV; Reines HD; Hunt P
    Surg Gynecol Obstet; 1986 Jun; 162(6):575-8. PubMed ID: 3012808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis.
    Stellato TA; Danziger LH; Hau T; Gauderer MW; Ferron JL; Gordon N
    Arch Surg; 1988 Jun; 123(6):714-7. PubMed ID: 3285809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous metronidazole or clindamycin with tobramycin for therapy of pelvic infections.
    Gall SA; Kohan AP; Ayers OM; Hughes CE; Addison WA; Hill GB
    Obstet Gynecol; 1981 Jan; 57(1):51-8. PubMed ID: 7005778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of intra-abdominal infections is appropriate with single-agent or combination antibiotic therapy.
    Malangoni MA; Condon RE; Spiegel CA
    Surgery; 1985 Oct; 98(4):648-55. PubMed ID: 3901372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of moxalactam with the combination of clindamycin and an aminoglycoside in the treatment of common surgical infections.
    Rambo WM; Del Bene VE; Burkey LG; Collins CD; Richmond DK
    Rev Infect Dis; 1982; 4 Suppl():S683-7. PubMed ID: 6218583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized study of moxalactam versus gentamicin and clindamycin in penetrating abdominal trauma.
    Kreis DJ; Augenstein D; Martinez O; Echenique M; Plasencia G; Vopal JJ; Byers P; Gomez GA
    Surg Gynecol Obstet; 1986 Jul; 163(1):1-4. PubMed ID: 3726718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost comparison of two antimicrobial regimens for treating mixed aerobic-anaerobic infections.
    Scheife RT; Tally FP; McGowan K; Gorbach SL
    Am J Hosp Pharm; 1981 Oct; 38(10):1466-9. PubMed ID: 7294038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective, randomized comparison of the efficacy and safety of netilmicin-clindamycin and tobramycin-clindamycin in the treatment of serious systemic infections.
    Kahalley S; Chandler J; Hawkins J; Norris G; Waugespack R; Snow RM
    Clin Ther; 1985; 7(4):497-506. PubMed ID: 4016829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime/clindamycin versus tobramycin/clindamycin in the treatment of intra-abdominal infections.
    Bubrick MP; Heim-Duthoy KL; Yellin AE; Berne TV; Heseltine PN; Appleman MD; Cocchetto DM; Matzke GR
    Am Surg; 1990 Oct; 56(10):613-7. PubMed ID: 2221611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cephalosporins with enhanced anti-anaerobic activity for treatment and prevention of anaerobic and mixed infections.
    DiPiro JT; May JR
    Clin Pharm; 1988 Apr; 7(4):285-302. PubMed ID: 3284692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefoxitin plus tobramycin and clindamycin plus tobramycin. A prospective randomized comparison in the therapy of mixed aerobic/anaerobic infections.
    Nicolle LE; Harding GK; Louie TJ; Thomson MJ; Blanchard RJ
    Arch Surg; 1986 Aug; 121(8):891-6. PubMed ID: 3524511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse peritonitis treated with tobramycin and clindamycin. Bacteria in relation to preoperative duration of illness.
    Lindblad B; Claesson B
    Acta Chir Scand; 1983; 149(6):573-8. PubMed ID: 6359795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients.
    Feld R; Louie TJ; Mandell L; Bow EJ; Robson HG; Chow A; Belch A; Miedzinski L; Rachlis A; Pater J
    Arch Intern Med; 1985 Jun; 145(6):1083-8. PubMed ID: 3890789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twice-daily moxalactam versus gentamicin and clindamycin in patients with penetrating abdominal trauma.
    Crots LD; Obeid FN; Horst HM; Bivins BA
    Clin Pharm; 1985; 4(3):316-20. PubMed ID: 3891203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized prospective study comparing moxalactam and cefoxitin with or without tobramycin for the treatment of serious surgical infections.
    Tally FP; Kellum JM; Ho JL; O'Donnell TF; Barza M; Gorbach SL
    Antimicrob Agents Chemother; 1986 Feb; 29(2):244-9. PubMed ID: 3717931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients.
    Fainstein V; Bodey GP; Bolivar R; Elting L; McCredie KB; Keating MJ
    Arch Intern Med; 1984 Sep; 144(9):1766-70. PubMed ID: 6383246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.